MoneyWorks4Me

Jenburkt Pharmaceuticals informs about compliances-certificate

08 Jul 2022 Evaluate
Jenburkt Pharmaceuticals has informed that it enclosed Certificate pursuant to regulation 74(5) of SEBI (D&P) Regulations, 2018 for the quarter ended on 30.06.2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..